Skip to content ↓

Energy Secretary Chu to speak May 12 at MIT

Nobel laureate to deliver Compton Lecture
Steven Chu
Caption:
Steven Chu

Nobel Laureate and U.S. Energy Secretary Steven Chu will visit MIT on May 12 and deliver the Compton Lecture. Chu's lecture is titled "The Energy Problem and the Interplay between Basic and Applied Research."

Chu, who won the Nobel Prize in physics in 1997 for his work on the cooling and trapping of atoms with laser light, is the first Nobel laureate to serve in a U.S. cabinet position. Until his DoE appointment he was a professor of physics at the University of California, Berkeley, and director of the Lawrence Berkeley National Laboratory.

Chu comes from a family of scholars, and his father, Ju Chin Chu, earned his doctorate in chemical engineering from MIT in 1946.

Chu will deliver the Compton Lecture in room 10-250 (Huntington Hall) at 4 p.m. on Tuesday, May 12. He will be introduced by MIT President Susan Hockfield. The lecture series, named in honor of Karl Taylor Compton, MIT's ninth president, began in 1957 and aims to give the MIT community direct contact with the important ideas of our times and with people who have contributed much to modern thought.

The Karl Taylor Compton lecture series is sponsored by the MIT president in conjunction with the Provost's Office.

A version of this article appeared in MIT Tech Talk on May 6, 2009 (download PDF).

Related Links

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story